Sir,

Patients presenting with intoxication comprise of an important part of emergency visits. Pyrethroids are widely used insecticides because they are about 2250 times more toxic to insects than mammals.\[[@ref1]\] The intoxications due to deltamethrin are rarely reported. We report a case of deltamethrin poisoning due to intentional oral ingestion as a suicidal attempt.

A 22-year-old female presented with nausea, vomiting, respiratory distress, altered sensorium, and generalized convulsions since 2 h to the emergency department of our institution. There was a history of around 50 ml of deltamethrin ingestion 4 h prior to admission as revealed by attendants. Vital signs were: Pulse rate-120 bpm, blood pressure-100/60 mmHg, respiratory rate-34/min, and SpO~2~(on oxygen through ventimask @ 6 l/min)-86%. The chest was clear, body temperature was 37.4°C, Glasgow coma scale (GCS) = E~1~V~1~M~3~ and pupils were mid-dilated and sluggishly reacting to light. She was administered 5 mg diazepam intravenously to control seizures, and tracheal intubation was carried out using modified rapid sequence induction. Investigations were: Blood glucose-110 mg/dl, blood urea-28 mg/dl, serum creatinine-0.8 mg/dl, serum sodium, potassium and chloride-140, 4, and 95 mmol/L respectively, serum calcium-8.6 mg/dl, lactate dehydrogenase-92 U/L, total bilirubin-0.9 mg/dl, SGOT/SGPT-30/32 U/L, and amylase-102 U/L. The patient was shifted to Respiratory Intensive Care Unit (RICU). Arterial blood gas (ABG) analysis: pH = 7.39, paO~2~= 98 mmHg, paCO~2~= 37.9 mmHg, HCO~3~= 20.9, SaO~2~= 97%. Electrocardiogram showed sinus tachycardia. The treatment comprised of injection furosemide 20 mg BD, sodium valproate 500 mg BD, and midazolam infusion @ 1 mcg/kg/min. She was hemodynamically stable; respiratory efforts were present, but the poor GCS persisted.

After 2 h suddenly the heart rate increased from 80 bpm to 140 bpm for which injection metoprolol 5 mg was administered intravenously but she developed paroxysmal supraventricular tachycardia (PSVT) \[[Figure 1](#F1){ref-type="fig"}\]. Injection adenosine 6 mg intravenous (IV) was given, but PSVT was not settled, and 12 mg IV was repeated. Possible causes were investigated and ruled out. The patient was afebrile, and an ABG with electrolytes was sent. The values were within normal limits. After 1-h, next episode of PSVT occurred which was accompanied by hypotension. Electrical cardioversion was done, but the patient did not respond. Subsequently, she had a cardiac arrest and despite all resuscitative measures could not be salvaged.

![Monitor showing paroxysmal supraventricular tachycardia](IJCCM-19-435-g001){#F1}

Pyrethroids are of two types: Type I-altherin, resmethrin, and permethrin; and Type II-deltamethrin, cypermethrin, and fenvalerate. Both types impair the ion transport across voltage sensitive sodium channels by delaying their closure. Type II pyrethroids also depress the chloride currents through voltage-dependent chloride channels.\[[@ref2]\] At higher concentrations, they act on GABA-gated chloride channels resulting in seizure activity.\[[@ref1]\] Signs of poisoning are headache, irritability, ataxia, hyperexcitation, convulsions, and death.\[[@ref3]\] There is no specific antidote for pyrethroid poisoning *per se*, and the management is symptomatic and supportive.\[[@ref4]\]

The cardiac toxicity with pyrethroids has not been reported yet. Though the seizures were controlled in RICU, but the possibility of nonconvulsive seizures cannot be negated as continuous electroencephalogram monitoring facility was not available at our center. Hence, neuroexcitation might have caused sympathetic surge leading to cardiac involvement. The other possibility could be the effect of deltamethrin on sodium channels of the myocardium causing delayed closure resulting in hyperexcitability. The exact mechanism, however, remains undefined.

To conclude, the inclusion of our case report to the literature provides new knowledge and information regarding poisoning due to deltamethrin, which will further aid intensivists in managing these patients.
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